SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-16-037175
Filing Date
2016-08-11
Accepted
2016-08-11 16:11:37
Documents
77
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q nby20160531_10q.htm 10-Q 1145150
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 11954
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 14017
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 7699
5 EXHIBIT 32.2 ex32-2.htm EX-32.2 7705
  Complete submission text file 0001437749-16-037175.txt   6262099

Data Files

Seq Description Document Type Size
6 EXHIBIT 101.INS nby-20160630.xml EX-101.INS 1204412
7 EXHIBIT 101.SCH nby-20160630.xsd EX-101.SCH 72912
8 EXHIBIT 101.CAL nby-20160630_cal.xml EX-101.CAL 39469
9 EXHIBIT 101.DEF nby-20160630_def.xml EX-101.DEF 495355
10 EXHIBIT 101.LAB nby-20160630_lab.xml EX-101.LAB 390697
11 EXHIBIT 101.PRE nby-20160630_pre.xml EX-101.PRE 517244
Mailing Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608
Business Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33678 | Film No.: 161824684
SIC: 2834 Pharmaceutical Preparations